Madrid, Spain.

Dr. Ori Zelichov and the NovellusDx team are attending the ESMO 2017 Congress, and will present early results from the SHIVA clinical study with Prof. Le Tourneau of the Institut Curie, Paris: Retrospective analysis of a SHIVA01 trial cohort using functional mutational analysis successfully predicted treatment outcome. The poster session will take place in Hall 8 on Monday, 2017-09-11, at 13:15-14:15.